We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

118 hedge funds and large institutions have $2.73B invested in Maravai LifeSciences in 2020 Q4 according to their latest regulatory filings, with 118 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,490% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $328K

100.83% more ownership

Funds ownership: 0% → 100.83% (+101%)

Holders
118
Holders Change
+118
Holders Change %
–
% of All Funds
2.09%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
118
Increased
–
Reduced
–
Closed
–
Calls
$5.21M
Puts
$328K
Net Calls
+$4.89M
Net Calls Change
+$4.89M

Top Buyers

Rank Fund Capital Flow
1
DCP
D1 Capital Partners
New York
+$165M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$159M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$131M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$118M
5
JP Morgan Chase
JP Morgan Chase
New York
+$115M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
51
STRS Ohio
Ohio
$2.99M +$2.97M +106,500 New
Victory Capital Management
52
Victory Capital Management
Texas
$2.95M +$2.92M +105,027 New
N
53
Nuveen
North Carolina
$2.81M +$2.78M +100,000 New
Bank of America
54
Bank of America
North Carolina
$2.62M +$2.6M +93,413 New
Goldman Sachs
55
Goldman Sachs
New York
$2.43M +$2.41M +86,569 New
FAM
56
Fred Alger Management
New York
$2.42M +$2.4M +86,296 New
MS
57
Maven Securities
Jersey
$2.32M +$2.31M +82,813 New
JG
58
Jefferies Group
New York
$2.26M +$2.24M +80,520 New
CSS
59
Cubist Systematic Strategies
Connecticut
$2.18M +$2.17M +77,789 New
Norges Bank
60
Norges Bank
Norway
$2.17M +$2.16M +77,418 New
PCM
61
Pinz Capital Management
New York
$2.09M +$2.08M +74,547 New
RI
62
RTW Investments
New York
$1.96M +$1.95M +70,000 New
Wells Fargo
63
Wells Fargo
California
$1.88M +$1.87M +67,021 New
Geode Capital Management
64
Geode Capital Management
Massachusetts
$1.81M +$1.79M +64,438 New
Natixis Advisors
65
Natixis Advisors
Massachusetts
$1.73M +$1.72M +61,814 New
Jane Street
66
Jane Street
New York
$1.65M +$1.64M +58,750 New
Two Sigma Advisers
67
Two Sigma Advisers
New York
$1.6M +$1.59M +57,000 New
Deutsche Bank
68
Deutsche Bank
Germany
$1.51M +$1.5M +53,949 New
ACI
69
AMP Capital Investors
Australia
$1.47M +$1.47M +52,689 New
TA
70
Tamarack Advisers
California
$1.37M +$1.39M +50,000 New
UBS Group
71
UBS Group
Switzerland
$1.01M +$999K +35,875 New
William Blair & Company
72
William Blair & Company
Illinois
$927K +$920K +33,054 New
ZP
73
Zimmer Partners
New York
$898K +$891K +32,000 New
PE
74
Point72 Europe
United Kingdom
$842K +$835K +30,000 New
SEI Investments
75
SEI Investments
Pennsylvania
$831K +$927K +33,274 New
1 2
3
4 5

MRVI Hedge Fund Activity: Q4 2020 in Review

118 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q4 2020, worth a combined $2.73B.

Buyers outnumbered sellers: 118 funds opened new MRVI positions and 0 closed out — a net gain of 118 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was D1 Capital Partners, opening a new position worth an estimated $165M.

  • 118 institutional investors held Maravai LifeSciences (MRVI) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $2.73B of Maravai LifeSciences stock for Q4 2020.
  • 118 funds opened new Maravai LifeSciences positions in Q4 2020 and 0 closed out, a net change of +118 holders.
  • The largest Maravai LifeSciences buyer in Q4 2020 was D1 Capital Partners, an estimated $165M added.

Based on aggregated 13F filings for Q4 2020.